We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Saturday
May 03
09:00 - 10:00
Stolz 2
Genito-urinary 3
Cem Onal, Turkey;
Charlien Berghen, Belgium
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Clinical
Urology
09:00 - 09:06
Concurrent chemoradiotherapy with Cisplatin and Gemcitabine in muscle-invasive bladder cancer: results of a prospective phase II trial (NCT01495676)
Morgan Michalet, France
E25-725
09:06 - 09:12
Dosimetric Analysis of Urethral and Bladder Toxicities: Insights from the Prospective HypoFocal II Trial (DRKS00017570, ARO2020-01)
Sophia Louisa Bürkle, Germany
E25-4434
09:12 - 09:18
Health-related quality of life in patients treated for non-metastatic muscle-invasive bladder cancer: radical cystectomy vs bladder preserving therapy
Katharina Brück, The Netherlands
E25-300
09:18 - 09:24
Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity from a randomised phase II study (GETUG-AFU 30)
Paul Sargos, France
E25-1921
09:24 - 09:30
Acute toxicity with SBRT vs fractionated IMRT to the prostate and pelvis in high-risk prostate cancer (SRAM): A randomized phase II study NCT03938649
Darren MC Poon, Hong Kong (SAR) China
E25-901
09:30 - 09:36
Interaction of genetic drivers and dose surface mapping for rectal toxicity following prostate cancer radiotherapy
Artemis Bouzaki, United Kingdom
E25-2570
09:36 - 09:42
Early results from a trial on stereotactic salvage radiotherapy for macroscopic prostate bed recurrence after prostatectomy: STARR (NCT05455736)
Niccolò Bertini, Italy
E25-1653
09:42 - 09:48
Pattern of care and survival outcomes in older men with localised prostate cancer in an Australian population-based cohort
Therese Kang, Australia
E25-4309
09:48 - 09:54
Elective irradiation of the para-aortic lymph nodes in pN1 prostate cancer: interim results of the multicentric, non-randomized phase 2 PART Trial
Gert De Meerleer, Belgium
E25-3462
09:54 - 10:00
RE-START: a national registry including patients undergoing reirradiation after previous RT for prostate cancer. A study on behalf of AIRO.
Giulio Francolini, Italy
E25-1021